以患者需求為核心，驅(qū)動(dòng)細(xì)胞免疫治療創(chuàng)新，實(shí)現(xiàn)癌癥可控化并最終治愈。
NK cells are safe in allogeneic applications and therefore are ideal off-the-shelf drugs.
NK cell-based therapeutics have shown satisfying safety profiles and promising efficiency in cancer treatment.
NK cells possess a reservoir of innate immune receptors targeting various types of cancer cells.
With proper engineering, NK cells can function as the universal anti-cancer drugs that are not restricted to HLA and cancer types.
粵公網(wǎng)安備 44011502000528號(hào)
中文
中文
0
